Vaxart Market Cap

Vaxart has a market cap or net worth of $182.08 million as of April 28, 2026. Its market cap has increased by 153.78% in one year.

Market Cap

182.08M

Enterprise Value

131.32M

Revenue

237.26M

Ranking

n/a

PE Ratio

10.79

Stock Price

$0.76

Market Cap Chart

Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 182.08M, an increase of 201.71%. That is a compound annual growth rate of 14.41%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	187.80M	125.91%
Dec 31, 2025	83.13M	-44.81%
Dec 31, 2024	150.61M	72.95%
Dec 29, 2023	87.09M	-30.95%
Dec 30, 2022	126.12M	-83.97%
Dec 31, 2021	786.86M	25.88%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Glorywin Entertainment Group	149.60M
Viskase Holdings	95.20M
Northwest Biotherapeutics	330.27M
HST Global	88.40M
Silence Therapeutics	363.70M
BioStem Technologies	81.91M
CytoDyn	408.44M
Nuo Therapeutics	62.92M

Market Cap Rankings